Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.
暂无分享,去创建一个
S. Yamashita | J. Sasaki | N. Yamada | H. Mabuchi | S. Oikawa | T. Teramoto | H. Itakura | Y. Hata | N. Tada | Hideki Ito | N. Sakuma | G. Egusa | M. Tsushima | Y. Saito | Y. Saito
[1] H. Keen,et al. The Bedford Survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics , 1982, Diabetologia.
[2] S. Yamashita,et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[3] Y. Yazaki,et al. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Tall,et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. , 1996, The Journal of clinical investigation.
[5] K. Satomura,et al. Target Levels for Plasma Lipids in Patients with Coronary Artery Disease: ―動脈硬化(冠・末梢)のある例で― , 1996 .
[6] H. Mabuchi. Current State of and Recent Trends in Serum Lipid Levels in the General Japanese Population , 1996 .
[7] S. Kihara,et al. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[8] T. Tamada,et al. [Age at natural menopause in Japanese women]. , 1995, Nihon Sanka Fujinka Gakkai zasshi.
[9] L. Coupal,et al. The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C. , 1995, JAMA.
[10] S. Grundy. Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy. , 1995, The American journal of cardiology.
[11] S. Yamashita,et al. Molecular Defect and Atherogenicity in Cholesteryl Ester Transfer Protein Deficiency , 1994, Annals of the New York Academy of Sciences.
[12] D. B. Zilversmit. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. , 1995, Clinical chemistry.
[13] J. Auget,et al. Comparative study of risk factors in patients undergoing coronary or femoropopliteal artery bypass grafting. , 1994, British heart journal.
[14] L. Martens,et al. Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease. , 1994, Clinical therapeutics.
[15] F. Follath,et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. , 1994, Circulation.
[16] Y. Stein. Comparison of European and USA guidelines for prevention of coronary heart disease. , 1994, Atherosclerosis.
[17] R. Krauss. Heterogeneity of plasma low‐density lipoproteins and atherosclerosis risk , 1994, Current opinion in lipidology.
[18] P. Poole‐Wilson,et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, European heart journal.
[19] J. Patsch,et al. Triglyceride-rich lipoproteins and atherosclerosis. , 1994, Atherosclerosis.
[20] W. A. Bradley,et al. Cellular binding site and membrane binding proteins for triglyceride-rich lipoproteins in human monocyte-macrophages and THP-1 monocytic cells. , 1994, Journal of lipid research.
[21] J. Després,et al. Relation of components of insulin resistance syndrome to coronary disease risk. , 1994, Current opinion in lipidology.
[22] T Nakamura,et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. , 1994, Atherosclerosis.
[23] A. Folsom,et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. , 1994, Circulation.
[24] C. Packard,et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. , 1994, Atherosclerosis.
[25] L. Wilkins. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .
[26] E. Schaefer,et al. Familial lipoprotein disorders and premature coronary artery disease. , 1993, The Medical clinics of North America.
[27] Y. Yamasaki,et al. Insulin Resistance Accelerates Atherosclerosis in Borderline Diabetes. , 1994 .
[28] Bradley Wa,et al. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. , 1994 .
[29] M. Uusitupa,et al. Long-term effects of three fat-modified diets in hypercholesterolemic subjects. , 1994, Atherosclerosis.
[30] J. Hokanson,et al. Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease. , 1994, The Medical clinics of North America.
[31] L. Wilkins,et al. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994, Circulation.
[32] G. Hallmans,et al. High serum insulin, insulin resistance and their associations with cardiovascular risk factors The Northern Sweden MONICA population study , 1993, Journal of internal medicine.
[33] P. Marckmann,et al. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis. , 1993, Atherosclerosis.
[34] J. Mckenney,et al. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.
[35] K. Frayn. Insulin resistance and lipid metabolism , 1993 .
[36] R. Krauss,et al. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. , 1993, The American journal of medicine.
[37] Reckless Jp. Cost-effectiveness of hypolipidaemic drugs. , 1993 .
[38] P. Wilson,et al. Change in LDL particle size is associated with change in plasma triglyceride concentration. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[39] M. Sentí,et al. Lipoprotein and Apolipoprotein Profile in Men With Ischemic Stroke: Role of Lipoprotein (a), Triglyceride‐Rich Lipoproteins, and Apolipoprotein E Polymorphism , 1992, Stroke.
[40] C. Kurata,et al. Coronary artery disease in patients with arteriosclerosis obliterans of the lower extremities or aortic aneurysm. , 1992, Internal medicine.
[41] R. Langer,et al. Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.
[42] T. Fujinami,et al. Relation of Serum Lipid Levels to the Presence and Severity of Angiographic Coronary Artery Disease in Japanese , 1992 .
[43] S. Grundy,et al. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment. , 1992, Archives of internal medicine.
[44] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[45] J. Salonen,et al. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[46] R. DeFronzo,et al. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.
[47] M. Austin. Plasma triglyceride and coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[48] D. Steinberg,et al. Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.
[49] N. Ohte,et al. Coronary risk factors in angiographically defined patients with chest pain. , 1990, Japanese journal of medicine.
[50] M. King,et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.
[51] A. Shiraishi,et al. Relationship between coronary risk factor and arteriographic feature of coronary atherosclerosis. , 1990, Japanese circulation journal.
[52] K. Kodama,et al. Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki study. , 1990, Japanese circulation journal.
[53] V. Fuster,et al. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.
[54] H. Shimano,et al. Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake. , 1990, The Journal of biological chemistry.
[55] J W Hay,et al. Medical costs of coronary artery disease in the United States. , 1990, The American journal of cardiology.
[56] J. Sasaki,et al. Alcohol consumption, serum lipids and severity of angiographically determined coronary artery disease. , 1990, The American journal of cardiology.
[57] M. Miller,et al. Isolated low HDL-cholesterol as an important risk factor for coronary heart disease. , 1990, European heart journal.
[58] J. Huttunen,et al. Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study. , 1989, The American journal of cardiology.
[59] S. Pocock,et al. Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. , 1989, BMJ.
[60] R. L. Rogers,et al. Reducing Hypertriglyceridemia in Elderly Patients with Cerebrovascular Disease Stabilizes or Improves Cognition and Cerebral Perfusion , 1989, Angiology.
[61] P. Welling,et al. The Clinical Pharmacokinetics of Quinapril , 1989, Angiology.
[62] N. Kaplan. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. , 1989, Archives of internal medicine.
[63] D. Gordon,et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.
[64] G. Rosenhamer,et al. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. , 2009, Acta medica Scandinavica.
[65] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[66] M. Barbir,et al. High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. , 1988, British heart journal.
[67] G. Yoshino,et al. Recommendation for Strict Control of Plasma Triglyceride in Diabetic Subjects , 1988, Diabetes Care.
[68] W. A. Bradley,et al. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins. , 1988, The Journal of clinical investigation.
[69] W C Willett,et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.
[70] W. Castelli,et al. Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study. , 1988, The Canadian journal of cardiology.
[71] A. Rimm,et al. RELATION OF TRIGLYCERIDE LEVELS TO CORONARY ARTERY DISEASE: THE MILWAUKEE CARDIOVASCULAR DATA REGISTRY , 1988 .
[72] P. Wilson,et al. High Density Lipoprotein Cholesterol, Total Cholesterol Screening, and Myocardial Infarction: The Framingham Study , 1988, Arteriosclerosis.
[73] C. Fielding,et al. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. , 1988, Biochemistry.
[74] Daniel Steinberg,et al. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.
[75] J. Reiber,et al. Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. , 1987, Atherosclerosis.
[76] P. Vague,et al. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1. , 1987, Diabete & metabolisme.
[77] Y. Matsuzawa,et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.
[78] P. Wilson,et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.
[79] J. Neaton,et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.
[80] F. Cambien,et al. Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study. , 1986, American journal of epidemiology.
[81] W. Castelli,et al. The triglyceride issue: a view from Framingham. , 1986, American heart journal.
[82] H. Mabuchi,et al. Causes of death in patients with familial hypercholesterolemia. , 1986, Atherosclerosis.
[83] L. Simons. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. , 1986, The American journal of cardiology.
[84] M. Kameyama,et al. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. , 1986, Atherosclerosis.
[85] M. Blombäck,et al. Haemostatic function in myocardial infarction. , 1986, British heart journal.
[86] M. Blombäck,et al. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.
[87] R. Mahley,et al. Lipoproteins of Special Significance in Atherosclerosis , 1985 .
[88] K. Hiwada,et al. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease. , 1985, Atherosclerosis.
[89] P A Wolf,et al. Risk factors for stroke. , 1985, Stroke.
[90] S. Grundy,et al. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. , 1985, Journal of lipid research.
[91] Y. Matsuzawa,et al. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. , 1984, Atherosclerosis.
[92] S. Eisenberg,et al. Plasma triglyceride determines structure-composition in low and high density lipoproteins. , 1984, Arteriosclerosis.
[93] E. Agner,et al. Fasting serum cholesterol and triglycerides in a ten-year prospective study in old age. , 2009, Acta medica Scandinavica.
[94] H. Sekimoto,et al. Changes of serum total cholesterol and triglyceride levels in normal subjects in Japan in the past twenty years. Research committee on familial hyperlipidemia in Japan. , 1983, Japanese circulation journal.
[95] J. Little,et al. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. , 1983, The Journal of biological chemistry.
[96] M. Feinleib,et al. Serum Triglyceride and Risk of Coronary Heart Disease, Stroke, and Total Mortality in Japanese‐American Men , 1983, Arteriosclerosis.
[97] R. Gregg,et al. Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment , 1983 .
[98] Y. Matsuzawa,et al. Coronary artery disease in heterozygous familial hypercholesterolemia. , 1982, Atherosclerosis.
[99] S. Grundy,et al. Influence of polyunsaturated fats on composition of plasma lipoproteins and apolipoproteins. , 1982, Journal of lipid research.
[100] W. A. Bradley,et al. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. , 1982, The Journal of clinical investigation.
[101] S. Daniels,et al. Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke. , 1982, Stroke.
[102] B. Lewis,et al. Relationships between the metabolism of high‐density and very‐low‐density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity , 1982, European journal of clinical investigation.
[103] M. Hamada,et al. Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives. , 1982, Atherosclerosis.
[104] W. Kannel,et al. Lipoproteins, cardiovascular disease, and death. The Framingham study. , 1981, Archives of internal medicine.
[105] L Wilhelmsen,et al. Multivariate Analyses of Serum Apolipoproteins and Risk Factors in Relation to Acute Myocardial Infarction , 1981, Arteriosclerosis.
[106] M. Kameyama,et al. Lipoprotein Abnormalities in the Pathogenesis of Cerebral Infarction and Transient Ischemic Attack , 1981, Stroke.
[107] G. Heiss,et al. The Epidemiology of Plasma High‐density Lipoprotein Cholesterol Levels: The Lipid Research Clinics Program Prevalence Study Summary , 1980, Circulation.
[108] L. Wilhelmsen,et al. Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. , 1980, Atherosclerosis.
[109] M. Shipley,et al. CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study , 1980, The Lancet.
[110] R. Bawol,et al. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. , 1980, The New England journal of medicine.
[111] A. Keys,et al. Seven countries. A multivariate analysis of death and coronary heart disease. , 1980 .
[112] S. Shapiro,et al. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[113] D. B. Zilversmit. Atherogenesis: a postprandial phenomenon. , 1979, Circulation.
[114] K. Pyörälä. Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland , 1979, Diabetes Care.
[115] J. Medalie,et al. High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. , 1979, American journal of epidemiology.
[116] T. Welborn,et al. Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations , 1979, Diabetes Care.
[117] S. Matsushita,et al. High and low density lipoprotein cholesterol in myocardial and cerebral infarction. , 1979, Atherosclerosis.
[118] S. Rössner,et al. Dyslipoproteinemia in patients with ischemic cerebro-vascular disease: a study of stroke before the age of 55. , 1978, Atherosclerosis.
[119] C. Packard,et al. Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. , 1978, The Journal of clinical investigation.
[120] M C Hjortland,et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.
[121] R. Worth,et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Coronary heart disease risk factors in Japan and Hawaii. , 1977, The American journal of cardiology.
[122] A. Motulsky,et al. Myocardial infarction in the familial forms of hypertriglyceridemia. , 1976, Metabolism: clinical and experimental.
[123] J. Meyer,et al. Hyperlipoproteinemia in occlusive cerebrovascular disease. , 1975, JAMA.
[124] W. Kannel,et al. Role of Lipids in the Development of Brain Infarction: The Framingham Study , 1974, Stroke.
[125] P. McNamara,et al. Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study , 1974, Diabetes.
[126] A. Motulsky,et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. , 1973, The Journal of clinical investigation.
[127] R. Farmer,et al. Hyperlipoproteinemia and pancreatitis. , 1973, The American journal of medicine.
[128] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[129] G. Odland,et al. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study. , 1970, The Journal of clinical investigation.
[130] J. Glomset,et al. The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.
[131] M. Albrink,et al. Serum triglycerides in coronary artery disease. , 1958, Transactions of the Association of American Physicians.